NEWS FROM CPHI

A bitter pill to swallow: young people dislike tablets more than old

19-Oct-2014 - Last updated on 19-Aug-2020 at 08:45 GMT

Some patients surveyed preferred taking effervescent medicines. (Picture: Raymond Gilford/Flickr)

Related tags Pharmaceutical formulation

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Related news

Related products

2023 State of Clinical Trial Technology Report

Florence Healthcare | 01-Mar-2023 | Insight Guide

Discover the trends shaping clinical trial technology in 2023, from Site Enablement to eISFs, integrations, and site-sponsor collaboration. This report...

Sofgen Pharmaceuticals obtains Drug Establishment License

Sofgen Pharmaceuticals | 23-Jan-2023 | Press Release

Health Canada certifies Sofgen Pharmaceuticals in Canadian Good Manufacturing Practices (GMP) for our compliance with the Food and Drug Regulations at...

Tackling Early Phase Development with First-In-Human Study Solutions

Altasciences | 25-Oct-2022 | Technical / White Paper

Bringing new drugs to market, from lead candidate selection through preclinical testing, to clinical proof of concept, is a complex, time-consuming, and...

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

A bitter pill to swallow: young people dislike tablets more than old

Related news

Related products

2023 State of Clinical Trial Technology Report

Sofgen Pharmaceuticals obtains Drug Establishment License

Tackling Early Phase Development with First-In-Human Study Solutions

The Complexities of Ophthalmic Drug Development

Related suppliers

Follow us

Products

Webinars

Headlines

Promotional Features

Outsourcing-Pharma

Resources